Connect with us

Technology

Azenta Life Sciences and Form Bio Announce Strategic Partnership to Advance AAV Gene Therapy Development

Published

12 months ago

on

Integrated solution aims to reduce time and cost to lead candidates, advancing safer and more effective gene therapies to patients faster.

BURLINGTON, Mass., May 13, 2025 /PRNewswire/ — Azenta, Inc. (Nasdaq: AZTA) today announced a strategic partnership between GENEWIZ from Azenta Life Sciences, a global provider of multiomics and synthetic solutions services, and Form Bio, a leading artificial intelligence (AI) life sciences technology company, to enhance adeno-associated virus (AAV) gene therapy development through a fully integrated sequencing and data analysis solution.

This partnership brings together GENEWIZ’s industry-leading next-generation sequencing services for AAV gene therapy with Form Bio’s AI- and machine learning-powered analysis pipelines. The integration of these capabilities aims to provide gene therapy developers with data-driven insights into AAV capsid contents, improving safety, efficacy, and manufacturability.

GENEWIZ will provide synthesis and packaging of transgene expression cassettes, complemented by high-quality, long-read sequencing services for AAV gene therapy. Form Bio will conduct comprehensive AAV Genome Integrity Characterization using Long-read AAV Analysis (LAAVA) software, identifying key opportunities to enhance vector integrity and safety, while providing actionable insights through detailed reporting. This combination enables a streamlined process that integrates sequencing, vector design, and development workflows, ultimately reducing time and cost to reach lead candidates, accelerating the path to market for innovative therapies.

“Our collaboration with Form Bio marks a major step forward in simplifying AAV gene therapy workflows,” said Ginger Zhou, President at GENEWIZ. “By combining our sequencing expertise with their cutting-edge analysis, we are enabling researchers to make more informed decisions and break through traditional hurdles found in gene therapy development.”

“Partnering with GENEWIZ allows us to embed our genome integrity insights directly into sequencing workflows,” said Andrew Busey, Co-Founder and CEO at Form Bio. “By integrating analysis earlier in the process, we’re helping gene therapy developers accelerate timelines, enhance vector safety, and improve the likelihood for clinical success.”

The partnership will officially launch at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) in May 2025, where both companies will be exhibiting (booth numbers 1711 and 1143). A poster highlighting their collaborative work “The Long and Short of It: Comparing Next Generation Sequencing Methods for Quality Control in AAV Development” will be presented on May 15, 5:30-7:00 pm EST, poster #1612.

About Form Bio

Form Bio delivers cutting-edge AI and computational solutions to accelerate therapeutic development in cell and gene therapy. With its proprietary FORMsightAI platform, Form Bio enables rapid in silico genome integrity characterization and optimization of nucleic acid-based therapies—streamlining lead candidate selection. By integrating AI-powered design with deep expertise in molecular biology, bioinformatics, software engineering, and data science, Form Bio empowers drug developers to enhance therapeutic safety, efficacy, and manufacturability while reducing time and costs.

Form Bio is headquartered in Austin, Texas with teams and offices throughout the US. For more information, visit www.formbio.com or follow us on LinkedIn.

About Azenta Life Sciences

Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling life science organizations around the world to bring impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for the industry’s top pharmaceutical, biotech, academic and healthcare institutions globally. Our global team delivers and supports these products and services through our industry-leading brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.

Azenta is headquartered in Burlington, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.

INVESTOR CONTACTS:
Yvonne Perron
Vice President, Financial Planning & Analysis, and Investor Relations
ir@azenta.com

Sherry Dinsmore
sherry.dinsmore@azenta.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/azenta-life-sciences-and-form-bio-announce-strategic-partnership-to-advance-aav-gene-therapy-development-302454449.html

SOURCE Azenta, Inc.

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Booking.com’s Latest Travel and Sustainability Research Reveals Australian Generational Paradox

Published

53 minutes ago

on

May 3, 2026

By

SYDNEY, May 4, 2026 /PRNewswire/ — Today Booking.com released its 11th annual research report into consumer attitudes and understanding of the social and environmental impact of travel. With insights from 32,500 travellers across 35 markets globally, including 1,000 from Australia, this year’s research highlights a generational paradox.

While 83% of Australian travellers say that more sustainable travel is important to them, older generations demonstrate greater commitment through concrete actions, despite younger generations often expressing stronger sustainability intentions.

Older generations demonstrate greater commitment through concrete sustainable actions, with almost two–thirds of Boomers across Asia Pacific (63%) saying they will shop more at local, independent stores on their trips, three–quarters (75%) planning to reduce general waste, and 63% intending to reduce energy consumption, higher than Gen X, Millennials and Gen Z.However, younger travellers are leading in cultural and conservation management; more than a quarter of Gen Z (27%) and Millennials (26%) participated in a tour or activity that contributed to the health or conservation of the local ecosystem or wildlife.Extreme weather is actively reshaping travel choices. Nearly three-quarters of Australian travellers said they consider extreme weather risk when choosing both destination (72%), and timing (75%), and 27% reported having cancelled or changed trip plans in the past twelve months due to extreme weather or natural disaster.Australian travellers are shifting when and where they travel, seeking reliable climates and comfort. 43% say they plan to avoid overcrowded tourist destinations, 42% plan to travel outside of peak season, and 26% will seek out destinations with cooler temperatures.In 2025, travellers booked more than 100 million room nights on Booking.com at accommodation partners with a third-party sustainability certification, including at 363 third-party certified Australian properties.

To find Booking.com’s full 2026 research, visit here.

 

View original content:https://www.prnewswire.com/apac/news-releases/bookingcoms-latest-travel-and-sustainability-research-reveals-australian-generational-paradox-302760310.html

SOURCE Booking.com

Continue Reading

Technology

Florida Physician Specialists Data Breach: Edelson Lechtzin LLP Launches Investigation into Exposure of Personal Information

Published

4 hours ago

on

May 3, 2026

By

National class action firm offering free case evaluations to individuals impacted by the Florida Physician Specialists cybersecurity incident

JACKSONVILLE, Fla., May 3, 2026 /PRNewswire/ — Edelson Lechtzin LLP, a national class action law firm, is investigating data privacy claims arising from the Florida Physician Specialists data breach. Florida Physician Specialists learned of the cybersecurity incident between November 27 and 29, 2025.

What Happened

Florida Physician Specialists discovered that its network was hacked between November 27 and 29, 2025. An investigation launched in late November 2025 confirmed that an unauthorized third party accessed its network. The review of the exposed data was completed on April 6, 2026.

Information Exposed

Affected personal data includes full names and one or more of the following: Social Security numbers, driver’s license numbers or state identification numbers, other government identification numbers, financial account information, credit or debit card information, medical information, and/or health insurance policy information.

Who May Be Impacted

Individuals who received a data breach notification from Florida Physician Specialists may face an increased risk of identity theft and fraud.

Your Legal Options

Edelson Lechtzin LLP is investigating a potential class action to pursue legal remedies on behalf of individuals whose sensitive personal data may have been compromised in the Florida Physician Specialists breach. The firm will evaluate your rights and potential claims at no cost.

Recommended Protective Steps

Review account statements and credit reports regularly and remain vigilant for suspicious activity. Confirm whether your information was involved in the Florida Physician Specialists incident and preserve any letters or emails you received about the breach. Consider placing fraud alerts and credit monitoring.

Contact Us for a Free Case Evaluation

Speak confidentially with a data privacy attorney today: Marc Edelson, Esq., Edelson Lechtzin LLP, 411 S. State Street, Suite N-300, Newtown, PA 18940; Phone: 844-696-7492 ext. 2; Email: medelson@edelson-law.com; Web: www.edelson-law.com. Or click HERE to request a free consultation.

About Florida Physician Specialists

Based in Jacksonville, Florida, Florida Physician Specialists is a multi-specialty private physician practice serving patients in Northeast Florida.

About Edelson Lechtzin LLP

Edelson Lechtzin LLP is a national class action law firm with offices in Pennsylvania and California. In addition to data breach litigation, the firm handles class and collective actions involving securities and investment fraud, federal antitrust violations, ERISA employee benefit plans, wage theft, and consumer fraud

Media and Partnership Inquiries: Use the contact information above to connect with our team regarding interviews, co-counsel opportunities, and referral partnerships.

Legal Notice: This press release may be considered Attorney Advertising in some jurisdictions.

View original content to download multimedia:https://www.prnewswire.com/news-releases/florida-physician-specialists-data-breach-edelson-lechtzin-llp-launches-investigation-into-exposure-of-personal-information-302760742.html

SOURCE Edelson Lechtzin LLP

Continue Reading

Technology

Sandhills Medical Foundation, Inc., d/b/a Sandhills Medical Data Breach: Edelson Lechtzin LLP Launches Investigation into Exposure of Personal Information

Published

4 hours ago

on

May 3, 2026

By

National class action firm offering free case evaluations to individuals impacted by the Sandhills Medical cybersecurity incident

MCBEE, S.C., May 3, 2026 /PRNewswire/ — Edelson Lechtzin LLP, a national class action law firm, is investigating data privacy claims arising from the Sandhills Medical data breach. Sandhills Medical learned of the cybersecurity incident between November 27 and 29, 2025.

What Happened

On May 8, 2025, Sandhills Medical discovered it had been the victim of a ransomware attack. Sandhills Medical began an investigation with the help of cybersecurity experts and a forensic firm. That investigation determined an unauthorized third party accessed Sandhills Medical’s server directly and obtained personal information for select patients.

Information Exposed

Affected personal data includes names, personal health information, and birth dates. This data breach has affected an estimated 169,017 people.

Who May Be Impacted

Individuals who received a data breach notification from Sandhills Medical may face an increased risk of identity theft and fraud.

Your Legal Options

Edelson Lechtzin LLP is investigating a potential class action to pursue legal remedies on behalf of individuals whose sensitive personal data may have been compromised in the Sandhills Medical breach. The firm will evaluate your rights and potential claims at no cost.

Recommended Protective Steps

Review account statements and credit reports regularly and remain vigilant for suspicious activity. Confirm whether your information was involved in the Sandhills Medical incident and preserve any letters or emails you received about the breach. Consider placing fraud alerts and credit monitoring.

Contact Us for a Free Case Evaluation

Speak confidentially with a data privacy attorney today: Marc Edelson, Esq., Edelson Lechtzin LLP, 411 S. State Street, Suite N-300, Newtown, PA 18940; Phone: 844-696-7492 ext. 2; Email: medelson@edelson-law.com; Web: www.edelson-law.com. Or click HERE to request a free consultation.

About Sandhills Medical

Based in McBee, South Carolina, Sandhills Medical operates as a Federally Qualified Community Health Center (FQHC) that provides community-based primary health care services.

About Edelson Lechtzin LLP

Edelson Lechtzin LLP is a national class action law firm with offices in Pennsylvania and California. In addition to data breach litigation, the firm handles class and collective actions involving securities and investment fraud, federal antitrust violations, ERISA employee benefit plans, wage theft, and consumer fraud

Media and Partnership Inquiries: Use the contact information above to connect with our team regarding interviews, co-counsel opportunities, and referral partnerships.

Legal Notice: This press release may be considered Attorney Advertising in some jurisdictions.

View original content to download multimedia:https://www.prnewswire.com/news-releases/sandhills-medical-foundation-inc-dba-sandhills-medical-data-breach-edelson-lechtzin-llp-launches-investigation-into-exposure-of-personal-information-302760743.html

SOURCE Edelson Lechtzin LLP

Continue Reading

Trending